The first simulated 3D heart has been presented and could predict responses to treatments

Dassault Systèmes announces the launch of the first model of the world based on virtual 3D simulation of the whole human heart. Developed with a multidisciplinary team of experts to help fight cardiovascular disease, “Living Heart” project will mark a new frontier in the diagnosis, treatment and prevention of heart disease through personalized 3D virtual models.

According to recent research from the World Health Organization, 17.3 million people died from cardiovascular diseases worldwide in 2008, representing 30% of all deaths. A report from the American Heart Association Forecasting the Future of Cardiovascular Disease in the United States consider actual direct medical costs of cardiovascular disease will reach 81,810 million dollars over the next 30 years.

In the center of the project is a 3D heart made with applications of virtual simulation platform Dassault Systèmes 3DEXPERIENCE platform. The simulation experts of the company have used the latest advances introduced in the SIMULIA applications to develop a complete 3D model of this organ, capturing the electrical and mechanical heart as realistic as possible and live performance.

Currently, the lack of realistic 3D human model limits the ability of researchers to predict the behavior of the devices in people. The Living Heart project has attracted a community of regulators multidisciplinary medical researchers, health professionals, device manufacturers and industry regulators, who have access to 3D computer modeling to accelerate the transformation of research into products and services for the market.

Using echocardiography, MRI images and CT scanner with cardiac screening data, the personalized heart 3D simulations will soon allow medical professionals to better understand the behavior of a patient’s heart without the need for additional invasive diagnostic procedures. 

This is useful for those with congenital heart defects, which necessarily require many cardiovascular treatments, but also for the large percentage of population suffering from heart failure, arrhythmias, and other structural abnormalities. This technology is a breakthrough that will accelerate the realization of our scientific advances on cardiac function in practical applications that promote better health and safety.

This realistic simulation of a human heart is a valuable educational and explanatory tool that promotes innovation in research, accelerates the cycles of regulatory approvals, reduces development costs of new custom devices and eventually will provide early diagnosis and improved treatment results. 

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...